fanta.bio Sample: CNhs10845
25645 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 973 / 10099 (9.6%) | 303 / 100990 (0.3%) | −324.0 | −324.0 | 32.11 |
| HIF1A SRX11007095 | HK-2 Kidney | 1805 / 10099 (17.9%) | 623 / 100990 (0.6%) | −324.0 | −324.0 | 28.97 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1356 / 10099 (13.4%) | 548 / 100990 (0.5%) | −324.0 | −324.0 | 24.74 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1231 / 10099 (12.2%) | 578 / 100990 (0.6%) | −324.0 | −324.0 | 21.30 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1708 / 10099 (16.9%) | 829 / 100990 (0.8%) | −324.0 | −324.0 | 20.60 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1647 / 10099 (16.3%) | 827 / 100990 (0.8%) | −324.0 | −324.0 | 19.92 |
| SCML2 SRX644728 | 293 Kidney | 963 / 10099 (9.5%) | 559 / 100990 (0.6%) | −324.0 | −324.0 | 17.23 |
| MYH11 SRX265221 | ME-1 Blood | 623 / 10099 (6.2%) | 396 / 100990 (0.4%) | −324.0 | −324.0 | 15.73 |
| FOXP1 SRX736067 | LNCAP Prostate | 1279 / 10099 (12.7%) | 814 / 100990 (0.8%) | −324.0 | −324.0 | 15.71 |
| BRD4 SRX9419935 | BT-474 Breast | 2347 / 10099 (23.2%) | 1928 / 100990 (1.9%) | −324.0 | −324.0 | 12.17 |
| MED1 SRX9419944 | BT-474 Breast | 2277 / 10099 (22.5%) | 1885 / 100990 (1.9%) | −324.0 | −324.0 | 12.08 |
| BRD4 SRX9419937 | BT-474 Breast | 2335 / 10099 (23.1%) | 1936 / 100990 (1.9%) | −324.0 | −324.0 | 12.06 |
| MED1 SRX9419945 | BT-474 Breast | 2342 / 10099 (23.2%) | 1953 / 100990 (1.9%) | −324.0 | −324.0 | 11.99 |
| MED1 SRX9419946 | BT-474 Breast | 2364 / 10099 (23.4%) | 2044 / 100990 (2.0%) | −324.0 | −324.0 | 11.57 |
| BRD4 SRX9419936 | BT-474 Breast | 2365 / 10099 (23.4%) | 2047 / 100990 (2.0%) | −324.0 | −324.0 | 11.55 |
| BRD4 SRX9419938 | BT-474 Breast | 2332 / 10099 (23.1%) | 2021 / 100990 (2.0%) | −324.0 | −324.0 | 11.54 |
| MED1 SRX9419947 | BT-474 Breast | 2278 / 10099 (22.6%) | 2020 / 100990 (2.0%) | −324.0 | −324.0 | 11.28 |
| EZH2 SRX2146136 | LNCAP Prostate | 5110 / 10099 (50.6%) | 5330 / 100990 (5.3%) | −324.0 | −324.0 | 9.59 |
| BRD4 SRX736201 | 90-8TL Neural | 4088 / 10099 (40.5%) | 4363 / 100990 (4.3%) | −324.0 | −324.0 | 9.37 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1209 / 10099 (12.0%) | 1705 / 100990 (1.7%) | −324.0 | −324.0 | 7.09 |
| TP53 SRX19538279 | Osteoblasts Bone | 448 / 10099 (4.4%) | 183 / 100990 (0.2%) | −314.2 | −311.0 | 24.48 |
| TP53 SRX19538276 | U2OS Bone | 371 / 10099 (3.7%) | 116 / 100990 (0.1%) | −279.0 | −275.8 | 31.98 |
| TP53 SRX19538274 | U2OS Bone | 366 / 10099 (3.6%) | 114 / 100990 (0.1%) | −275.4 | −272.3 | 32.11 |
| TP53 SRX19538268 | U2OS Bone | 363 / 10099 (3.6%) | 115 / 100990 (0.1%) | −272.0 | −268.9 | 31.57 |
| TP53 SRX19538267 | U2OS Bone | 331 / 10099 (3.3%) | 90 / 100990 (0.1%) | −256.9 | −253.8 | 36.78 |
| HIF1A SRX20663235 | HK-2 Kidney | 383 / 10099 (3.8%) | 191 / 100990 (0.2%) | −252.2 | −249.1 | 20.05 |
| TP53 SRX19538280 | Osteoblasts Bone | 353 / 10099 (3.5%) | 136 / 100990 (0.1%) | −251.3 | −248.3 | 25.96 |
| TP53 SRX19538275 | U2OS Bone | 335 / 10099 (3.3%) | 110 / 100990 (0.1%) | −248.8 | −245.7 | 30.45 |
| TP53 SRX19538273 | U2OS Bone | 328 / 10099 (3.2%) | 102 / 100990 (0.1%) | −246.8 | −243.8 | 32.16 |
| TP53 SRX19538269 | U2OS Bone | 405 / 10099 (4.0%) | 268 / 100990 (0.3%) | −240.7 | −237.6 | 15.11 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 346 / 10099 (3.4%) | 151 / 100990 (0.1%) | −237.6 | −234.6 | 22.91 |
| IRF3 SRX11453858 | Hep G2 Liver | 282 / 10099 (2.8%) | 55 / 100990 (0.1%) | −233.6 | −230.5 | 51.27 |
| TP53 SRX19538281 | Osteoblasts Bone | 368 / 10099 (3.6%) | 206 / 100990 (0.2%) | −232.9 | −229.9 | 17.86 |
| TP53 SRX19538270 | U2OS Bone | 373 / 10099 (3.7%) | 264 / 100990 (0.3%) | −215.5 | −212.5 | 14.13 |
| IRF3 SRX11453861 | Hep G2 Liver | 257 / 10099 (2.5%) | 52 / 100990 (0.1%) | −211.4 | −208.5 | 49.42 |
| BRD4 SRX736204 | 90-8TL Neural | 766 / 10099 (7.6%) | 1736 / 100990 (1.7%) | −209.0 | −206.0 | 4.41 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 869 / 10099 (8.6%) | 2248 / 100990 (2.2%) | −207.0 | −204.1 | 3.87 |
| KAT6A SRX20971022 | Fibroblasts Others | 252 / 10099 (2.5%) | 53 / 100990 (0.1%) | −205.9 | −202.9 | 47.55 |
| PBX4 SRX2731658 | PC-3 Prostate | 569 / 10099 (5.6%) | 15837 / 100990 (15.7%) | −198.9 | −196.0 | 0.36 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1006 / 10099 (10.0%) | 3063 / 100990 (3.0%) | −197.9 | −195.0 | 3.28 |
| TP53 SRX19538282 | Osteoblasts Bone | 312 / 10099 (3.1%) | 194 / 100990 (0.2%) | −189.8 | −186.8 | 16.08 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 462 / 10099 (4.6%) | 634 / 100990 (0.6%) | −188.0 | −185.1 | 7.29 |
| AGO2 SRX4708039 | Hep G2 Liver | 1240 / 10099 (12.3%) | 4556 / 100990 (4.5%) | −187.8 | −184.9 | 2.72 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 652 / 10099 (6.5%) | 1400 / 100990 (1.4%) | −186.7 | −183.8 | 4.66 |
| TP53 SRX19538271 | U2OS Bone | 488 / 10099 (4.8%) | 741 / 100990 (0.7%) | −185.3 | −182.4 | 6.59 |
| AR SRX10820653 | LNCAP Prostate | 277 / 10099 (2.7%) | 135 / 100990 (0.1%) | −183.6 | −180.7 | 20.52 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 426 / 10099 (4.2%) | 608 / 100990 (0.6%) | −168.7 | −165.9 | 7.01 |
| 5-mC SRX882970 | LNCAP Prostate | 1878 / 10099 (18.6%) | 9205 / 100990 (9.1%) | −168.7 | −165.8 | 2.04 |
| 5-mC SRX882968 | LNCAP Prostate | 1845 / 10099 (18.3%) | 9135 / 100990 (9.0%) | −161.4 | −158.5 | 2.02 |
| TP53 SRX19538272 | U2OS Bone | 423 / 10099 (4.2%) | 682 / 100990 (0.7%) | −153.4 | −150.6 | 6.20 |
| AR SRX10820651 | LNCAP Prostate | 270 / 10099 (2.7%) | 199 / 100990 (0.2%) | −153.2 | −150.4 | 13.57 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 214 / 10099 (2.1%) | 83 / 100990 (0.1%) | −152.0 | −149.2 | 25.78 |
| Epitope tags SRX10549776 | K-562 Blood | 910 / 10099 (9.0%) | 3150 / 100990 (3.1%) | −148.8 | −146.0 | 2.89 |
| 5-mC SRX882965 | LNCAP Prostate | 1525 / 10099 (15.1%) | 7154 / 100990 (7.1%) | −147.9 | −145.1 | 2.13 |
| RUNX1 SRX2513054 | 293 Kidney | 2017 / 10099 (20.0%) | 10779 / 100990 (10.7%) | −146.9 | −144.1 | 1.87 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 446 / 10099 (4.4%) | 818 / 100990 (0.8%) | −146.1 | −143.4 | 5.45 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 390 / 10099 (3.9%) | 610 / 100990 (0.6%) | −144.6 | −141.9 | 6.39 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 334 / 10099 (3.3%) | 436 / 100990 (0.4%) | −140.2 | −137.4 | 7.66 |
| FOS SRX150477 | MCF 10A Breast | 424 / 10099 (4.2%) | 11643 / 100990 (11.5%) | −139.0 | −136.3 | 0.36 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1312 / 10099 (13.0%) | 5899 / 100990 (5.8%) | −137.6 | −134.9 | 2.22 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 330 / 10099 (3.3%) | 442 / 100990 (0.4%) | −136.2 | −133.5 | 7.47 |
| FOS SRX150478 | MCF 10A Breast | 454 / 10099 (4.5%) | 11982 / 100990 (11.9%) | −135.7 | −132.9 | 0.38 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 188 / 10099 (1.9%) | 70 / 100990 (0.1%) | −135.1 | −132.3 | 26.86 |
| NFYB SRX16608147 | HeLa Uterus | 215 / 10099 (2.1%) | 124 / 100990 (0.1%) | −134.5 | −131.8 | 17.34 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 766 / 10099 (7.6%) | 2572 / 100990 (2.5%) | −130.2 | −127.5 | 2.98 |
| STAT5B SRX831881 | CD8+ T cells Blood | 192 / 10099 (1.9%) | 97 / 100990 (0.1%) | −125.8 | −123.1 | 19.79 |
| FOXA1 SRX176862 | MCF-7 Breast | 241 / 10099 (2.4%) | 8279 / 100990 (8.2%) | −125.6 | −122.9 | 0.29 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 425 / 10099 (4.2%) | 882 / 100990 (0.9%) | −124.9 | −122.2 | 4.82 |
| FOXA1 SRX4815198 | MCF-7 Breast | 652 / 10099 (6.5%) | 14418 / 100990 (14.3%) | −124.6 | −121.9 | 0.45 |
| AGO2 SRX6783958 | Hep G2 Liver | 769 / 10099 (7.6%) | 2680 / 100990 (2.7%) | −123.6 | −121.0 | 2.87 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 434 / 10099 (4.3%) | 11238 / 100990 (11.1%) | −123.1 | −120.5 | 0.39 |
| BMI1 SRX644729 | 293 Kidney | 188 / 10099 (1.9%) | 98 / 100990 (0.1%) | −121.9 | −119.2 | 19.18 |
| AGO2 SRX6783957 | Hep G2 Liver | 778 / 10099 (7.7%) | 2761 / 100990 (2.7%) | −121.7 | −119.0 | 2.82 |
| YAP1 SRX757325 | H2052 Lung | 503 / 10099 (5.0%) | 12132 / 100990 (12.0%) | −119.9 | −117.2 | 0.41 |
| FOS SRX4192880 | MCF 10A Breast | 333 / 10099 (3.3%) | 9538 / 100990 (9.4%) | −118.6 | −115.9 | 0.35 |
| GATA3 SRX190239 | MCF-7 Breast | 279 / 10099 (2.8%) | 8663 / 100990 (8.6%) | −118.1 | −115.4 | 0.32 |
| ESR1 SRX371469 | MCF-7 Breast | 191 / 10099 (1.9%) | 7158 / 100990 (7.1%) | −117.4 | −114.8 | 0.27 |
| FOXA1 SRX176863 | MCF-7 Breast | 238 / 10099 (2.4%) | 7898 / 100990 (7.8%) | −115.3 | −112.7 | 0.30 |
| SSRP1 SRX3436567 | HT-1080 Bone | 274 / 10099 (2.7%) | 358 / 100990 (0.4%) | −114.9 | −112.3 | 7.65 |
| ESR1 SRX371478 | MCF-7 Breast | 249 / 10099 (2.5%) | 8057 / 100990 (8.0%) | −114.7 | −112.1 | 0.31 |
| ESR1 SRX7624157 | MCF-7 Breast | 517 / 10099 (5.1%) | 12047 / 100990 (11.9%) | −112.3 | −109.7 | 0.43 |
| FOXA1 SRX4815197 | MCF-7 Breast | 497 / 10099 (4.9%) | 11762 / 100990 (11.6%) | −112.3 | −109.7 | 0.42 |
| YAP1 SRX757326 | H2052 Lung | 434 / 10099 (4.3%) | 10837 / 100990 (10.7%) | −112.1 | −109.5 | 0.40 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 359 / 10099 (3.6%) | 699 / 100990 (0.7%) | −111.6 | −109.0 | 5.14 |
| ESR1 SRX4367193 | MCF-7 Breast | 653 / 10099 (6.5%) | 13912 / 100990 (13.8%) | −111.4 | −108.8 | 0.47 |
| FOXA1 SRX371482 | MCF-7 Breast | 298 / 10099 (3.0%) | 8703 / 100990 (8.6%) | −110.2 | −107.6 | 0.34 |
| CIC SRX13262055 | Astrocytes Neural | 1788 / 10099 (17.7%) | 10111 / 100990 (10.0%) | −108.7 | −106.1 | 1.77 |
| ESR1 SRX371479 | MCF-7 Breast | 180 / 10099 (1.8%) | 6695 / 100990 (6.6%) | −108.7 | −106.1 | 0.27 |
| ESR1 SRX7624156 | MCF-7 Breast | 324 / 10099 (3.2%) | 9040 / 100990 (9.0%) | −108.2 | −105.7 | 0.36 |
| ESR1 SRX20282961 | MCF-7 Breast | 255 / 10099 (2.5%) | 7941 / 100990 (7.9%) | −108.2 | −105.6 | 0.32 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 820 / 10099 (8.1%) | 3249 / 100990 (3.2%) | −107.0 | −104.4 | 2.52 |
| FOXA1 SRX1161177 | MCF-7 Breast | 210 / 10099 (2.1%) | 7114 / 100990 (7.0%) | −105.7 | −103.1 | 0.30 |
| FOXA1 SRX371483 | MCF-7 Breast | 235 / 10099 (2.3%) | 7516 / 100990 (7.4%) | −105.2 | −102.7 | 0.31 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1035 / 10099 (10.2%) | 4701 / 100990 (4.7%) | −104.5 | −102.0 | 2.20 |
| FOXA1 SRX371481 | MCF-7 Breast | 222 / 10099 (2.2%) | 7256 / 100990 (7.2%) | −103.8 | −101.2 | 0.31 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 510 / 10099 (5.1%) | 1501 / 100990 (1.5%) | −102.8 | −100.3 | 3.40 |
| CDK9 SRX7366783 | MCF-7 Breast | 169 / 10099 (1.7%) | 106 / 100990 (0.1%) | −102.5 | −100.0 | 15.94 |
| ESR1 SRX371470 | ZR-75-1 Breast | 186 / 10099 (1.8%) | 6589 / 100990 (6.5%) | −102.0 | −99.5 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 467 / 10099 (4.6%) | 10929 / 100990 (10.8%) | −101.8 | −99.3 | 0.43 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 161 / 10099 (1.6%) | 6140 / 100990 (6.1%) | −101.7 | −99.1 | 0.26 |
| FOS SRX150517 | MCF 10A Breast | 367 / 10099 (3.6%) | 9460 / 100990 (9.4%) | −101.7 | −99.1 | 0.39 |
| ESR1 SRX176860 | MCF-7 Breast | 356 / 10099 (3.5%) | 9278 / 100990 (9.2%) | −101.2 | −98.7 | 0.38 |
| FOXA1 SRX1161176 | MCF-7 Breast | 208 / 10099 (2.1%) | 6927 / 100990 (6.9%) | −101.0 | −98.5 | 0.30 |
| ESR1 SRX371467 | MCF-7 Breast | 217 / 10099 (2.1%) | 7074 / 100990 (7.0%) | −100.8 | −98.3 | 0.31 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 545 / 10099 (5.4%) | 1716 / 100990 (1.7%) | −100.6 | −98.1 | 3.18 |
| ESR1 SRX371476 | MCF-7 Breast | 152 / 10099 (1.5%) | 5946 / 100990 (5.9%) | −100.5 | −98.0 | 0.26 |
| MethylCap SRX014767 | NB-4 Blood | 1042 / 10099 (10.3%) | 4847 / 100990 (4.8%) | −100.1 | −97.6 | 2.15 |
| JUNB SRX8488088 | SUM 229PE Breast | 414 / 10099 (4.1%) | 10089 / 100990 (10.0%) | −99.8 | −97.3 | 0.41 |
| LEO1 SRX1873456 | SEM Blood | 867 / 10099 (8.6%) | 3689 / 100990 (3.7%) | −99.3 | −96.8 | 2.35 |
| FOS SRX150476 | MCF 10A Breast | 375 / 10099 (3.7%) | 9482 / 100990 (9.4%) | −99.1 | −96.6 | 0.40 |
| ETS1 SRX3033231 | HEYA8 Gonad | 200 / 10099 (2.0%) | 197 / 100990 (0.2%) | −98.9 | −96.4 | 10.15 |
| TLE3 SRX4815191 | MCF-7 Breast | 213 / 10099 (2.1%) | 6931 / 100990 (6.9%) | −98.4 | −96.0 | 0.31 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 732 / 10099 (7.2%) | 14394 / 100990 (14.3%) | −97.6 | −95.1 | 0.51 |
| ESR1 SRX194569 | MCF-7 Breast | 223 / 10099 (2.2%) | 7064 / 100990 (7.0%) | −97.6 | −95.1 | 0.32 |
| CDK9 SRX7366781 | MCF-7 Breast | 157 / 10099 (1.6%) | 93 / 100990 (0.1%) | −97.4 | −94.9 | 16.88 |
| ESR1 SRX371471 | ZR-75-1 Breast | 236 / 10099 (2.3%) | 7267 / 100990 (7.2%) | −97.2 | −94.7 | 0.32 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 144 / 10099 (1.4%) | 67 / 100990 (0.1%) | −97.0 | −94.6 | 21.49 |
| FOXA1 SRX371480 | MCF-7 Breast | 142 / 10099 (1.4%) | 5637 / 100990 (5.6%) | −96.4 | −93.9 | 0.25 |
| SREBF2 SRX5359048 | HCC70 Breast | 998 / 10099 (9.9%) | 4630 / 100990 (4.6%) | −96.2 | −93.7 | 2.16 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 145 / 10099 (1.4%) | 71 / 100990 (0.1%) | −96.1 | −93.7 | 20.42 |
| ESR1 SRX20282960 | MCF-7 Breast | 251 / 10099 (2.5%) | 7449 / 100990 (7.4%) | −95.5 | −93.1 | 0.34 |
| KAT7 SRX101303 | RKO Digestive tract | 768 / 10099 (7.6%) | 3124 / 100990 (3.1%) | −95.2 | −92.8 | 2.46 |
| FOXA1 SRX1161173 | MCF-7 Breast | 178 / 10099 (1.8%) | 6230 / 100990 (6.2%) | −95.2 | −92.8 | 0.29 |
| MethylCap SRX014766 | NB-4 Blood | 941 / 10099 (9.3%) | 4268 / 100990 (4.2%) | −94.8 | −92.4 | 2.20 |
| TRP47 SRX4548329 | THP-1 Blood | 1524 / 10099 (15.1%) | 8499 / 100990 (8.4%) | −94.8 | −92.4 | 1.79 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 450 / 10099 (4.5%) | 1279 / 100990 (1.3%) | −94.6 | −92.2 | 3.52 |
| ESR1 SRX371468 | MCF-7 Breast | 136 / 10099 (1.3%) | 5456 / 100990 (5.4%) | −94.1 | −91.7 | 0.25 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 263 / 10099 (2.6%) | 7576 / 100990 (7.5%) | −93.7 | −91.3 | 0.35 |
| ESR1 SRX1531791 | MCF-7 Breast | 213 / 10099 (2.1%) | 6761 / 100990 (6.7%) | −93.4 | −91.0 | 0.32 |
| BRD1 SRX286203 | RKO Digestive tract | 672 / 10099 (6.7%) | 2562 / 100990 (2.5%) | −93.1 | −90.7 | 2.62 |
| GATA3 SRX176864 | MCF-7 Breast | 161 / 10099 (1.6%) | 5867 / 100990 (5.8%) | −93.0 | −90.6 | 0.27 |
| ESR1 SRX176861 | MCF-7 Breast | 376 / 10099 (3.7%) | 9259 / 100990 (9.2%) | −92.7 | −90.3 | 0.41 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 306 / 10099 (3.0%) | 614 / 100990 (0.6%) | −92.6 | −90.2 | 4.98 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 326 / 10099 (3.2%) | 8498 / 100990 (8.4%) | −92.3 | −89.9 | 0.38 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 222 / 10099 (2.2%) | 6859 / 100990 (6.8%) | −92.0 | −89.6 | 0.32 |
| ESR1 SRX20282939 | MCF-7 Breast | 259 / 10099 (2.6%) | 7451 / 100990 (7.4%) | −91.8 | −89.4 | 0.35 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1055 / 10099 (10.4%) | 5131 / 100990 (5.1%) | −91.5 | −89.1 | 2.06 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 332 / 10099 (3.3%) | 8536 / 100990 (8.5%) | −90.8 | −88.4 | 0.39 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 460 / 10099 (4.6%) | 1379 / 100990 (1.4%) | −90.5 | −88.1 | 3.34 |
| BMI1 SRX7196721 | SF8628 Neural | 997 / 10099 (9.9%) | 4751 / 100990 (4.7%) | −90.4 | −88.1 | 2.10 |
| ESR1 SRX194572 | MCF-7 Breast | 141 / 10099 (1.4%) | 5429 / 100990 (5.4%) | −90.4 | −88.0 | 0.26 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 310 / 10099 (3.1%) | 8177 / 100990 (8.1%) | −90.1 | −87.7 | 0.38 |
| SSRP1 SRX3436566 | HT-1080 Bone | 204 / 10099 (2.0%) | 246 / 100990 (0.2%) | −90.0 | −87.7 | 8.29 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 185 / 10099 (1.8%) | 189 / 100990 (0.2%) | −89.8 | −87.4 | 9.79 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 214 / 10099 (2.1%) | 6653 / 100990 (6.6%) | −89.8 | −87.4 | 0.32 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 395 / 10099 (3.9%) | 9406 / 100990 (9.3%) | −89.2 | −86.8 | 0.42 |
| BRPF3 SRX796085 | RKO Digestive tract | 605 / 10099 (6.0%) | 2235 / 100990 (2.2%) | −88.2 | −85.8 | 2.71 |
| FOXA1 SRX100454 | T-47D Breast | 303 / 10099 (3.0%) | 7988 / 100990 (7.9%) | −87.8 | −85.4 | 0.38 |
| TP53 SRX396254 | Fibroblasts Others | 508 / 10099 (5.0%) | 1682 / 100990 (1.7%) | −87.3 | −85.0 | 3.02 |
| BRPF3 SRX796084 | RKO Digestive tract | 839 / 10099 (8.3%) | 3748 / 100990 (3.7%) | −87.0 | −84.7 | 2.24 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 308 / 10099 (3.0%) | 8033 / 100990 (8.0%) | −86.9 | −84.6 | 0.38 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 757 / 10099 (7.5%) | 14240 / 100990 (14.1%) | −86.8 | −84.5 | 0.53 |
| FOXA1 SRX1161175 | MCF-7 Breast | 179 / 10099 (1.8%) | 5973 / 100990 (5.9%) | −86.8 | −84.4 | 0.30 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1094 / 10099 (10.8%) | 5529 / 100990 (5.5%) | −86.7 | −84.4 | 1.98 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 165 / 10099 (1.6%) | 5730 / 100990 (5.7%) | −86.7 | −84.3 | 0.29 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 448 / 10099 (4.4%) | 10058 / 100990 (10.0%) | −86.5 | −84.2 | 0.45 |
| ESR1 SRX20282972 | MCF-7 Breast | 262 / 10099 (2.6%) | 7302 / 100990 (7.2%) | −86.3 | −84.0 | 0.36 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 509 / 10099 (5.0%) | 10903 / 100990 (10.8%) | −86.3 | −84.0 | 0.47 |
| GATA3 SRX5057632 | MCF-7 Breast | 152 / 10099 (1.5%) | 5482 / 100990 (5.4%) | −85.9 | −83.6 | 0.28 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 217 / 10099 (2.1%) | 6570 / 100990 (6.5%) | −85.9 | −83.5 | 0.33 |
| ESR1 SRX20282954 | MCF-7 Breast | 258 / 10099 (2.6%) | 7220 / 100990 (7.1%) | −85.8 | −83.5 | 0.36 |
| BRPF3 SRX796086 | RKO Digestive tract | 804 / 10099 (8.0%) | 3542 / 100990 (3.5%) | −85.6 | −83.2 | 2.27 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1096 / 10099 (10.9%) | 5574 / 100990 (5.5%) | −85.5 | −83.2 | 1.97 |
| FOXA1 SRX1787653 | MCF-7 Breast | 196 / 10099 (1.9%) | 6213 / 100990 (6.2%) | −85.5 | −83.2 | 0.32 |
| FOS SRX4192879 | MCF 10A Breast | 272 / 10099 (2.7%) | 7424 / 100990 (7.4%) | −85.4 | −83.1 | 0.37 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 220 / 10099 (2.2%) | 6594 / 100990 (6.5%) | −85.1 | −82.8 | 0.33 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 396 / 10099 (3.9%) | 1106 / 100990 (1.1%) | −85.0 | −82.7 | 3.58 |
| ESR1 SRX4367192 | MCF-7 Breast | 472 / 10099 (4.7%) | 10331 / 100990 (10.2%) | −84.9 | −82.6 | 0.46 |
| ESR1 SRX371477 | MCF-7 Breast | 112 / 10099 (1.1%) | 4728 / 100990 (4.7%) | −84.7 | −82.4 | 0.24 |
| ESR1 SRX371475 | BT-474 Breast | 114 / 10099 (1.1%) | 4766 / 100990 (4.7%) | −84.7 | −82.4 | 0.24 |
| ESR1 SRX2943591 | MCF-7 Breast | 162 / 10099 (1.6%) | 5612 / 100990 (5.6%) | −84.5 | −82.2 | 0.29 |
| ARID1A SRX5089376 | MCF-7 Breast | 208 / 10099 (2.1%) | 6361 / 100990 (6.3%) | −84.1 | −81.8 | 0.33 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 286 / 10099 (2.8%) | 7586 / 100990 (7.5%) | −84.0 | −81.7 | 0.38 |
| ESR1 SRX371474 | BT-474 Breast | 105 / 10099 (1.0%) | 4564 / 100990 (4.5%) | −83.6 | −81.3 | 0.23 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 124 / 10099 (1.2%) | 58 / 100990 (0.1%) | −83.5 | −81.2 | 21.38 |
| MITF SRX1555436 | 501A Epidermis | 1111 / 10099 (11.0%) | 5734 / 100990 (5.7%) | −83.4 | −81.2 | 1.94 |
| ESR1 SRX20282973 | MCF-7 Breast | 283 / 10099 (2.8%) | 7523 / 100990 (7.4%) | −83.4 | −81.2 | 0.38 |
| FOXA1 SRX1161174 | MCF-7 Breast | 253 / 10099 (2.5%) | 7048 / 100990 (7.0%) | −83.1 | −80.9 | 0.36 |
| FOS SRX3322636 | MCF-7 Breast | 152 / 10099 (1.5%) | 5383 / 100990 (5.3%) | −82.7 | −80.4 | 0.28 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 462 / 10099 (4.6%) | 10098 / 100990 (10.0%) | −82.7 | −80.4 | 0.46 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 336 / 10099 (3.3%) | 834 / 100990 (0.8%) | −82.5 | −80.2 | 4.03 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 318 / 10099 (3.1%) | 8009 / 100990 (7.9%) | −82.3 | −80.1 | 0.40 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 922 / 10099 (9.1%) | 4417 / 100990 (4.4%) | −82.3 | −80.0 | 2.09 |
| ESR1 SRX20282946 | MCF-7 Breast | 139 / 10099 (1.4%) | 5136 / 100990 (5.1%) | −82.2 | −79.9 | 0.27 |
| RUNX1 SRX2014504 | Jurkat Blood | 1374 / 10099 (13.6%) | 7743 / 100990 (7.7%) | −82.1 | −79.8 | 1.77 |
| MECOM SRX23677885 | HNT-34 Blood | 991 / 10099 (9.8%) | 4914 / 100990 (4.9%) | −81.8 | −79.5 | 2.02 |
| RELA SRX5938177 | FaDu Others | 220 / 10099 (2.2%) | 6479 / 100990 (6.4%) | −81.7 | −79.5 | 0.34 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 409 / 10099 (4.0%) | 9315 / 100990 (9.2%) | −81.7 | −79.5 | 0.44 |
| ESR1 SRX20282940 | MCF-7 Breast | 261 / 10099 (2.6%) | 7119 / 100990 (7.0%) | −81.7 | −79.5 | 0.37 |
| ESR1 SRX20282955 | MCF-7 Breast | 254 / 10099 (2.5%) | 6989 / 100990 (6.9%) | −81.0 | −78.8 | 0.36 |
| RAC1 SRX10365541 | MCF-7 Breast | 129 / 10099 (1.3%) | 4922 / 100990 (4.9%) | −80.9 | −78.7 | 0.26 |
| SMARCA4 SRX5212362 | Mel270 Others | 415 / 10099 (4.1%) | 9361 / 100990 (9.3%) | −80.8 | −78.6 | 0.44 |
| IRF3 SRX11453864 | Hep G2 Liver | 104 / 10099 (1.0%) | 29 / 100990 (0.0%) | −80.5 | −78.2 | 35.86 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 403 / 10099 (4.0%) | 9173 / 100990 (9.1%) | −80.3 | −78.1 | 0.44 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 248 / 10099 (2.5%) | 6845 / 100990 (6.8%) | −79.7 | −77.5 | 0.36 |
| RELA SRX2207673 | HUVEC Cardiovascular | 842 / 10099 (8.3%) | 14991 / 100990 (14.8%) | −79.6 | −77.4 | 0.56 |
| KAT6A SRX20971024 | Fibroblasts Others | 104 / 10099 (1.0%) | 31 / 100990 (0.0%) | −79.3 | −77.0 | 33.55 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 880 / 10099 (8.7%) | 4198 / 100990 (4.2%) | −79.2 | −77.0 | 2.10 |
| JUNB SRX10119386 | MCF 10A Breast | 222 / 10099 (2.2%) | 6411 / 100990 (6.3%) | −78.9 | −76.7 | 0.35 |
| DNA-RNA hybrid SRX15232261 | MDA-MB-436 Breast | 184 / 10099 (1.8%) | 233 / 100990 (0.2%) | −78.8 | −76.6 | 7.90 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 634 / 10099 (6.3%) | 12268 / 100990 (12.1%) | −78.8 | −76.6 | 0.52 |
| ESR1 SRX2881000 | MCF-7 Breast | 210 / 10099 (2.1%) | 6206 / 100990 (6.1%) | −78.6 | −76.4 | 0.34 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 202 / 10099 (2.0%) | 6074 / 100990 (6.0%) | −78.5 | −76.3 | 0.33 |
| ARID1A SRX5089379 | MCF-7 Breast | 248 / 10099 (2.5%) | 6798 / 100990 (6.7%) | −78.4 | −76.2 | 0.36 |
| SMARCA4 SRX5212366 | Mel270 Others | 332 / 10099 (3.3%) | 8062 / 100990 (8.0%) | −78.2 | −76.0 | 0.41 |
| FOXA1 SRX11222437 | MCF-7 Breast | 184 / 10099 (1.8%) | 5767 / 100990 (5.7%) | −78.1 | −75.9 | 0.32 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 252 / 10099 (2.5%) | 6851 / 100990 (6.8%) | −78.1 | −75.9 | 0.37 |
| GATA3 SRX5457550 | MCF-7 Breast | 281 / 10099 (2.8%) | 7296 / 100990 (7.2%) | −78.1 | −75.9 | 0.39 |
| ESR1 SRX20282953 | MCF-7 Breast | 198 / 10099 (2.0%) | 5993 / 100990 (5.9%) | −78.1 | −75.9 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 133 / 10099 (1.3%) | 4893 / 100990 (4.8%) | −77.8 | −75.6 | 0.27 |
| TLE3 SRX4815192 | MCF-7 Breast | 230 / 10099 (2.3%) | 6487 / 100990 (6.4%) | −77.6 | −75.4 | 0.35 |
| MECOM SRX23677884 | HNT-34 Blood | 965 / 10099 (9.6%) | 4837 / 100990 (4.8%) | −77.5 | −75.3 | 2.00 |
| ING5 SRX286202 | RKO Digestive tract | 717 / 10099 (7.1%) | 3131 / 100990 (3.1%) | −77.5 | −75.3 | 2.29 |
| FOXA1 SRX3923514 | MCF-7 Breast | 261 / 10099 (2.6%) | 6957 / 100990 (6.9%) | −77.3 | −75.1 | 0.38 |
| FOXA1 SRX11222441 | MCF-7 Breast | 198 / 10099 (2.0%) | 5961 / 100990 (5.9%) | −77.1 | −74.9 | 0.33 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 200 / 10099 (2.0%) | 5980 / 100990 (5.9%) | −76.7 | −74.5 | 0.33 |
| TEAD1 SRX3401272 | MCF-7 Breast | 192 / 10099 (1.9%) | 5848 / 100990 (5.8%) | −76.6 | −74.5 | 0.33 |
| MECOM SRX23677897 | HNT-34 Blood | 1145 / 10099 (11.3%) | 6184 / 100990 (6.1%) | −76.3 | −74.2 | 1.85 |
| MECOM SRX23677896 | HNT-34 Blood | 1182 / 10099 (11.7%) | 6460 / 100990 (6.4%) | −76.3 | −74.1 | 1.83 |
| ESR1 SRX2881002 | MCF-7 Breast | 236 / 10099 (2.3%) | 6532 / 100990 (6.5%) | −76.1 | −73.9 | 0.36 |
| SMARCA4 SRX5212357 | Mel270 Others | 359 / 10099 (3.6%) | 8369 / 100990 (8.3%) | −76.0 | −73.9 | 0.43 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 958 / 10099 (9.5%) | 4826 / 100990 (4.8%) | −76.0 | −73.8 | 1.99 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1008 / 10099 (10.0%) | 5184 / 100990 (5.1%) | −76.0 | −73.8 | 1.94 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 722 / 10099 (7.1%) | 13279 / 100990 (13.1%) | −75.8 | −73.6 | 0.54 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 215 / 10099 (2.1%) | 6189 / 100990 (6.1%) | −75.7 | −73.6 | 0.35 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 437 / 10099 (4.3%) | 9462 / 100990 (9.4%) | −75.6 | −73.5 | 0.46 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 762 / 10099 (7.5%) | 13777 / 100990 (13.6%) | −75.5 | −73.3 | 0.55 |
| KMT2A SRX2323891 | 293 Kidney | 554 / 10099 (5.5%) | 2129 / 100990 (2.1%) | −75.5 | −73.3 | 2.60 |
| NR2F2 SRX190293 | MCF-7 Breast | 262 / 10099 (2.6%) | 6898 / 100990 (6.8%) | −75.2 | −73.1 | 0.38 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 123 / 10099 (1.2%) | 4622 / 100990 (4.6%) | −74.9 | −72.7 | 0.27 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 287 / 10099 (2.8%) | 7254 / 100990 (7.2%) | −74.6 | −72.5 | 0.40 |
| Epitope tags SRX5877912 | U2OS Bone | 1330 / 10099 (13.2%) | 20689 / 100990 (20.5%) | −74.6 | −72.5 | 0.64 |
| ESR1 SRX10365536 | MCF-7 Breast | 139 / 10099 (1.4%) | 4877 / 100990 (4.8%) | −74.1 | −72.0 | 0.29 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 240 / 10099 (2.4%) | 6517 / 100990 (6.5%) | −74.0 | −71.9 | 0.37 |
| JUN SRX4192884 | MCF 10A Breast | 219 / 10099 (2.2%) | 6186 / 100990 (6.1%) | −74.0 | −71.9 | 0.35 |
| JUN SRX17561461 | LPS141 Adipocyte | 377 / 10099 (3.7%) | 8541 / 100990 (8.5%) | −73.9 | −71.7 | 0.44 |
| RELA SRX2207672 | HUVEC Cardiovascular | 927 / 10099 (9.2%) | 15777 / 100990 (15.6%) | −73.9 | −71.7 | 0.59 |
| SMARCA4 SRX5212371 | Mel270 Others | 359 / 10099 (3.6%) | 8279 / 100990 (8.2%) | −73.7 | −71.6 | 0.43 |
| Epitope tags SRX2255894 | 293 Kidney | 764 / 10099 (7.6%) | 3524 / 100990 (3.5%) | −73.6 | −71.5 | 2.17 |
| Epitope tags SRX10549777 | K-562 Blood | 1352 / 10099 (13.4%) | 7847 / 100990 (7.8%) | −73.5 | −71.4 | 1.72 |
| JUN SRX883584 | MDA-MB-231 Breast | 403 / 10099 (4.0%) | 8891 / 100990 (8.8%) | −73.4 | −71.3 | 0.45 |
| EP300 SRX176885 | MCF-7 Breast | 133 / 10099 (1.3%) | 4749 / 100990 (4.7%) | −73.4 | −71.3 | 0.28 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 238 / 10099 (2.4%) | 6463 / 100990 (6.4%) | −73.4 | −71.2 | 0.37 |
| PTEN SRX5416007 | SMMC-7721 Liver | 985 / 10099 (9.8%) | 5090 / 100990 (5.0%) | −73.3 | −71.2 | 1.94 |
| GATA3 SRX190194 | SK-N-SH Neural | 584 / 10099 (5.8%) | 11361 / 100990 (11.2%) | −73.3 | −71.2 | 0.51 |
| ZEB1 SRX13298925 | MCF-7 Breast | 157 / 10099 (1.6%) | 5154 / 100990 (5.1%) | −73.3 | −71.1 | 0.30 |
| CEBPB SRX150632 | HeLa Uterus | 564 / 10099 (5.6%) | 11087 / 100990 (11.0%) | −73.2 | −71.0 | 0.51 |
| LARP7 SRX2198835 | HeLa Uterus | 1177 / 10099 (11.7%) | 6522 / 100990 (6.5%) | −73.0 | −70.9 | 1.80 |
| FOXA1 SRX1787652 | MCF-7 Breast | 165 / 10099 (1.6%) | 5270 / 100990 (5.2%) | −72.8 | −70.6 | 0.31 |
| AR SRX9469988 | LAPC-4 Prostate | 347 / 10099 (3.4%) | 8064 / 100990 (8.0%) | −72.7 | −70.6 | 0.43 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 983 / 10099 (9.7%) | 5093 / 100990 (5.0%) | −72.6 | −70.5 | 1.93 |
| ESR1 SRX10365535 | MCF-7 Breast | 210 / 10099 (2.1%) | 5995 / 100990 (5.9%) | −72.6 | −70.5 | 0.35 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 281 / 10099 (2.8%) | 7085 / 100990 (7.0%) | −72.5 | −70.4 | 0.40 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 363 / 10099 (3.6%) | 8288 / 100990 (8.2%) | −72.5 | −70.4 | 0.44 |
| CDK9 SRX7366779 | MCF-7 Breast | 123 / 10099 (1.2%) | 84 / 100990 (0.1%) | −72.3 | −70.2 | 14.64 |
| ESR1 SRX20282971 | MCF-7 Breast | 253 / 10099 (2.5%) | 6652 / 100990 (6.6%) | −72.3 | −70.2 | 0.38 |
| RORC SRX5359052 | HCC70 Breast | 704 / 10099 (7.0%) | 3153 / 100990 (3.1%) | −72.2 | −70.1 | 2.23 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 680 / 10099 (6.7%) | 2994 / 100990 (3.0%) | −72.2 | −70.1 | 2.27 |
| RORC SRX5359053 | HCC70 Breast | 685 / 10099 (6.8%) | 3027 / 100990 (3.0%) | −72.2 | −70.1 | 2.26 |
| EP300 SRX1012648 | MCF-7 Breast | 123 / 10099 (1.2%) | 4528 / 100990 (4.5%) | −72.0 | −69.9 | 0.27 |
| JUNB SRX4192882 | MCF 10A Breast | 211 / 10099 (2.1%) | 5987 / 100990 (5.9%) | −71.9 | −69.8 | 0.35 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 121 / 10099 (1.2%) | 81 / 100990 (0.1%) | −71.7 | −69.6 | 14.94 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 259 / 10099 (2.6%) | 6725 / 100990 (6.7%) | −71.7 | −69.6 | 0.39 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 538 / 10099 (5.3%) | 10668 / 100990 (10.6%) | −71.7 | −69.6 | 0.50 |
| ESR1 SRX330070 | MCF-7 Breast | 134 / 10099 (1.3%) | 4709 / 100990 (4.7%) | −71.7 | −69.6 | 0.28 |
| FOXA1 SRX1447317 | MCF-7 Breast | 177 / 10099 (1.8%) | 5430 / 100990 (5.4%) | −71.6 | −69.5 | 0.33 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 270 / 10099 (2.7%) | 623 / 100990 (0.6%) | −71.6 | −69.5 | 4.33 |
| VGLL1 SRX24602130 | BT-20 Breast | 273 / 10099 (2.7%) | 6923 / 100990 (6.9%) | −71.4 | −69.3 | 0.39 |
| FOXA1 SRX5323843 | MCF-7 Breast | 142 / 10099 (1.4%) | 4838 / 100990 (4.8%) | −71.4 | −69.3 | 0.29 |
| YAP1 SRX5718140 | 293 Kidney | 439 / 10099 (4.3%) | 9307 / 100990 (9.2%) | −71.3 | −69.2 | 0.47 |
| FOXA1 SRX028634 | MCF-7 Breast | 134 / 10099 (1.3%) | 4695 / 100990 (4.6%) | −71.2 | −69.2 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 236 / 10099 (2.3%) | 6352 / 100990 (6.3%) | −71.2 | −69.1 | 0.37 |
| TET2 SRX1427029 | 293 Kidney | 715 / 10099 (7.1%) | 3248 / 100990 (3.2%) | −71.2 | −69.1 | 2.20 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 258 / 10099 (2.6%) | 6678 / 100990 (6.6%) | −71.0 | −68.9 | 0.39 |
| NKX2-1 SRX2164786 | A549 Lung | 429 / 10099 (4.2%) | 9149 / 100990 (9.1%) | −70.8 | −68.7 | 0.47 |
| FOXA2 SRX3230382 | Hep G2 Liver | 360 / 10099 (3.6%) | 8171 / 100990 (8.1%) | −70.8 | −68.7 | 0.44 |
| PGR SRX1012655 | MCF-7 Breast | 169 / 10099 (1.7%) | 5272 / 100990 (5.2%) | −70.8 | −68.7 | 0.32 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 282 / 10099 (2.8%) | 7030 / 100990 (7.0%) | −70.7 | −68.6 | 0.40 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1145 / 10099 (11.3%) | 6352 / 100990 (6.3%) | −70.7 | −68.6 | 1.80 |
| MEAF6 DRX234811 | 293 Kidney | 910 / 10099 (9.0%) | 4619 / 100990 (4.6%) | −70.6 | −68.5 | 1.97 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1046 / 10099 (10.4%) | 5613 / 100990 (5.6%) | −70.6 | −68.5 | 1.86 |
| Epitope tags SRX10549778 | K-562 Blood | 602 / 10099 (6.0%) | 2514 / 100990 (2.5%) | −70.6 | −68.5 | 2.39 |
| FOXA1 SRX11222442 | MCF-7 Breast | 184 / 10099 (1.8%) | 5508 / 100990 (5.5%) | −70.5 | −68.5 | 0.33 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 250 / 10099 (2.5%) | 6541 / 100990 (6.5%) | −70.5 | −68.4 | 0.38 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 712 / 10099 (7.1%) | 12896 / 100990 (12.8%) | −70.5 | −68.4 | 0.55 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 619 / 10099 (6.1%) | 11685 / 100990 (11.6%) | −70.4 | −68.3 | 0.53 |
| MEAF6 DRX300417 | 293 Kidney | 835 / 10099 (8.3%) | 4093 / 100990 (4.1%) | −70.2 | −68.2 | 2.04 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 131 / 10099 (1.3%) | 4611 / 100990 (4.6%) | −70.2 | −68.2 | 0.28 |
| ESR1 SRX3123829 | MCF-7 Breast | 150 / 10099 (1.5%) | 4933 / 100990 (4.9%) | −70.1 | −68.1 | 0.30 |
| ARID1A SRX5089385 | MCF-7 Breast | 204 / 10099 (2.0%) | 5811 / 100990 (5.8%) | −70.1 | −68.0 | 0.35 |
| JUNB SRX8488089 | SUM 229PE Breast | 270 / 10099 (2.7%) | 6829 / 100990 (6.8%) | −70.1 | −68.0 | 0.40 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 600 / 10099 (5.9%) | 11419 / 100990 (11.3%) | −70.0 | −67.9 | 0.53 |
| KAT7 DRX234808 | 293 Kidney | 419 / 10099 (4.1%) | 1412 / 100990 (1.4%) | −69.9 | −67.9 | 2.97 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 251 / 10099 (2.5%) | 6531 / 100990 (6.5%) | −69.9 | −67.8 | 0.38 |
| ESR1 SRX3110725 | MCF-7 Breast | 235 / 10099 (2.3%) | 6289 / 100990 (6.2%) | −69.9 | −67.8 | 0.37 |
| FOXA1 SRX028635 | MCF-7 Breast | 137 / 10099 (1.4%) | 4699 / 100990 (4.7%) | −69.7 | −67.7 | 0.29 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 246 / 10099 (2.4%) | 6449 / 100990 (6.4%) | −69.7 | −67.7 | 0.38 |
| FOXA1 SRX11222438 | MCF-7 Breast | 147 / 10099 (1.5%) | 4866 / 100990 (4.8%) | −69.7 | −67.6 | 0.30 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 257 / 10099 (2.5%) | 6600 / 100990 (6.5%) | −69.3 | −67.3 | 0.39 |
| GATA3 SRX6712581 | MCF-7 Breast | 225 / 10099 (2.2%) | 6104 / 100990 (6.0%) | −69.1 | −67.0 | 0.37 |
| TFAP2C SRX018833 | MCF-7 Breast | 239 / 10099 (2.4%) | 6319 / 100990 (6.3%) | −69.0 | −67.0 | 0.38 |
| Epitope tags DRX443510 | 293 Kidney | 781 / 10099 (7.7%) | 3749 / 100990 (3.7%) | −69.0 | −66.9 | 2.08 |
| FOXA1 SRX3931043 | MCF-7 Breast | 278 / 10099 (2.8%) | 6907 / 100990 (6.8%) | −69.0 | −66.9 | 0.40 |
| ESR1 SRX1531796 | MCF-7 Breast | 140 / 10099 (1.4%) | 4723 / 100990 (4.7%) | −68.9 | −66.9 | 0.30 |
| DAXX SRX1021630 | PC-3 Prostate | 271 / 10099 (2.7%) | 6793 / 100990 (6.7%) | −68.7 | −66.7 | 0.40 |
| FOXA1 SRX3931054 | MCF-7 Breast | 260 / 10099 (2.6%) | 6625 / 100990 (6.6%) | −68.7 | −66.7 | 0.39 |
| Epitope tags SRX5877914 | U2OS Bone | 1351 / 10099 (13.4%) | 20597 / 100990 (20.4%) | −68.7 | −66.6 | 0.66 |
| FOXA1 SRX1787651 | MCF-7 Breast | 162 / 10099 (1.6%) | 5079 / 100990 (5.0%) | −68.6 | −66.6 | 0.32 |
| ESR1 SRX8537722 | MCF-7 Breast | 248 / 10099 (2.5%) | 6438 / 100990 (6.4%) | −68.6 | −66.5 | 0.39 |
| JUNB SRX8488073 | SUM 229PE Breast | 489 / 10099 (4.8%) | 9870 / 100990 (9.8%) | −68.6 | −66.5 | 0.50 |
| TFAP2C SRX128099 | MCF-7 Breast | 241 / 10099 (2.4%) | 6322 / 100990 (6.3%) | −68.4 | −66.4 | 0.38 |
| ESR1 SRX1012629 | MCF-7 Breast | 166 / 10099 (1.6%) | 5140 / 100990 (5.1%) | −68.4 | −66.3 | 0.32 |
| GRHL3 SRX2582162 | NHEK Epidermis | 570 / 10099 (5.6%) | 2352 / 100990 (2.3%) | −68.4 | −66.3 | 2.42 |
| FOXA1 SRX100506 | Hep G2 Liver | 364 / 10099 (3.6%) | 8118 / 100990 (8.0%) | −68.0 | −66.0 | 0.45 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 223 / 10099 (2.2%) | 6034 / 100990 (6.0%) | −68.0 | −66.0 | 0.37 |
| GATA3 SRX100559 | T-47D Breast | 292 / 10099 (2.9%) | 7076 / 100990 (7.0%) | −68.0 | −66.0 | 0.41 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 874 / 10099 (8.7%) | 14805 / 100990 (14.7%) | −67.8 | −65.8 | 0.59 |
| STAT3 SRX2020842 | HCC70 Breast | 468 / 10099 (4.6%) | 9555 / 100990 (9.5%) | −67.8 | −65.8 | 0.49 |
| JUNB SRX10119384 | MCF 10A Breast | 170 / 10099 (1.7%) | 5178 / 100990 (5.1%) | −67.6 | −65.6 | 0.33 |
| AR SRX1067071 | LHSAR Prostate | 526 / 10099 (5.2%) | 10330 / 100990 (10.2%) | −67.6 | −65.6 | 0.51 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 514 / 10099 (5.1%) | 10161 / 100990 (10.1%) | −67.5 | −65.5 | 0.51 |
| NANOG SRX10445309 | Neural crest cells Neural | 153 / 10099 (1.5%) | 4891 / 100990 (4.8%) | −67.4 | −65.4 | 0.31 |
| ESR1 SRX792933 | LY2 Breast | 222 / 10099 (2.2%) | 5996 / 100990 (5.9%) | −67.4 | −65.4 | 0.37 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 261 / 10099 (2.6%) | 6587 / 100990 (6.5%) | −67.4 | −65.3 | 0.40 |
| ESR1 SRX1012632 | MCF-7 Breast | 134 / 10099 (1.3%) | 4568 / 100990 (4.5%) | −67.3 | −65.3 | 0.29 |
| ESR1 SRX5323873 | MCF-7 Breast | 327 / 10099 (3.2%) | 7555 / 100990 (7.5%) | −67.2 | −65.2 | 0.43 |
| ESR1 SRX4451213 | MCF-7 Breast | 270 / 10099 (2.7%) | 6719 / 100990 (6.7%) | −67.2 | −65.2 | 0.40 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1034 / 10099 (10.2%) | 5623 / 100990 (5.6%) | −67.1 | −65.1 | 1.84 |
| ESR1 SRX2943589 | MCF-7 Breast | 141 / 10099 (1.4%) | 4676 / 100990 (4.6%) | −67.1 | −65.1 | 0.30 |
| FOSL2 SRX190296 | SK-N-SH Neural | 358 / 10099 (3.5%) | 7991 / 100990 (7.9%) | −67.0 | −65.0 | 0.45 |
| FOXA1 SRX3923516 | MCF-7 Breast | 205 / 10099 (2.0%) | 5714 / 100990 (5.7%) | −67.0 | −65.0 | 0.36 |
| TET2 SRX2014505 | Jurkat Blood | 1444 / 10099 (14.3%) | 8809 / 100990 (8.7%) | −66.7 | −64.7 | 1.64 |
| ESR1 SRX330069 | MCF-7 Breast | 171 / 10099 (1.7%) | 5163 / 100990 (5.1%) | −66.7 | −64.7 | 0.33 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 356 / 10099 (3.5%) | 7948 / 100990 (7.9%) | −66.6 | −64.6 | 0.45 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 365 / 10099 (3.6%) | 8069 / 100990 (8.0%) | −66.6 | −64.6 | 0.45 |
| FOXA1 SRX3923517 | MCF-7 Breast | 202 / 10099 (2.0%) | 5648 / 100990 (5.6%) | −66.4 | −64.4 | 0.36 |
| CEBPA SRX4705113 | MOLM-13 Blood | 602 / 10099 (6.0%) | 11272 / 100990 (11.2%) | −66.4 | −64.4 | 0.53 |
| ESR1 SRX10365532 | MCF-7 Breast | 152 / 10099 (1.5%) | 4837 / 100990 (4.8%) | −66.4 | −64.4 | 0.31 |
| ESR1 SRX20282938 | MCF-7 Breast | 219 / 10099 (2.2%) | 5905 / 100990 (5.8%) | −66.2 | −64.2 | 0.37 |
| ESR1 SRX20282959 | MCF-7 Breast | 114 / 10099 (1.1%) | 4182 / 100990 (4.1%) | −66.2 | −64.2 | 0.27 |
| NCOA1 SRX036638 | U2OS Bone | 98 / 10099 (1.0%) | 46 / 100990 (0.0%) | −66.1 | −64.1 | 21.30 |
| FOXA1 SRX1161203 | T-47D Breast | 203 / 10099 (2.0%) | 5648 / 100990 (5.6%) | −66.0 | −64.1 | 0.36 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 390 / 10099 (3.9%) | 8401 / 100990 (8.3%) | −66.0 | −64.0 | 0.46 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 257 / 10099 (2.5%) | 6474 / 100990 (6.4%) | −65.9 | −63.9 | 0.40 |
| TCF12 SRX190356 | SK-N-SH Neural | 696 / 10099 (6.9%) | 12465 / 100990 (12.3%) | −65.8 | −63.9 | 0.56 |
| FOXA1 SRX1787655 | MCF-7 Breast | 148 / 10099 (1.5%) | 4751 / 100990 (4.7%) | −65.8 | −63.8 | 0.31 |
| JUND SRX150408 | HeLa Uterus | 245 / 10099 (2.4%) | 6286 / 100990 (6.2%) | −65.8 | −63.8 | 0.39 |
| ERG SRX063922 | K-562 Blood | 838 / 10099 (8.3%) | 4231 / 100990 (4.2%) | −65.7 | −63.7 | 1.98 |
| EP300 SRX1012643 | MCF-7 Breast | 104 / 10099 (1.0%) | 3984 / 100990 (3.9%) | −65.6 | −63.6 | 0.26 |
| FOXA1 SRX3931055 | MCF-7 Breast | 246 / 10099 (2.4%) | 6284 / 100990 (6.2%) | −65.3 | −63.3 | 0.39 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 234 / 10099 (2.3%) | 6091 / 100990 (6.0%) | −65.0 | −63.1 | 0.38 |
| ZEB1 SRX13298923 | MCF-7 Breast | 121 / 10099 (1.2%) | 4268 / 100990 (4.2%) | −65.0 | −63.0 | 0.28 |
| FOXA1 SRX1961157 | T-47D Breast | 302 / 10099 (3.0%) | 7101 / 100990 (7.0%) | −64.9 | −63.0 | 0.43 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 354 / 10099 (3.5%) | 7848 / 100990 (7.8%) | −64.9 | −63.0 | 0.45 |
| ARID1A SRX5089382 | MCF-7 Breast | 201 / 10099 (2.0%) | 5576 / 100990 (5.5%) | −64.9 | −62.9 | 0.36 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 321 / 10099 (3.2%) | 7366 / 100990 (7.3%) | −64.7 | −62.7 | 0.44 |
| FOXA2 SRX100448 | Hep G2 Liver | 313 / 10099 (3.1%) | 7249 / 100990 (7.2%) | −64.6 | −62.6 | 0.43 |
| ESR1 SRX4451212 | MCF-7 Breast | 259 / 10099 (2.6%) | 6451 / 100990 (6.4%) | −64.6 | −62.6 | 0.40 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 321 / 10099 (3.2%) | 7353 / 100990 (7.3%) | −64.3 | −62.4 | 0.44 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 300 / 10099 (3.0%) | 840 / 100990 (0.8%) | −64.2 | −62.2 | 3.57 |
| CDK9 SRX7366782 | MCF-7 Breast | 107 / 10099 (1.1%) | 70 / 100990 (0.1%) | −64.1 | −62.2 | 15.29 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 208 / 10099 (2.1%) | 5657 / 100990 (5.6%) | −64.1 | −62.1 | 0.37 |
| FOXA1 SRX1787654 | MCF-7 Breast | 109 / 10099 (1.1%) | 4025 / 100990 (4.0%) | −64.0 | −62.1 | 0.27 |
| ERG SRX063921 | K-562 Blood | 788 / 10099 (7.8%) | 3918 / 100990 (3.9%) | −64.0 | −62.0 | 2.01 |
| EP300 SRX1012644 | MCF-7 Breast | 132 / 10099 (1.3%) | 4418 / 100990 (4.4%) | −63.9 | −61.9 | 0.30 |
| SOX13 SRX2636248 | Hep G2 Liver | 385 / 10099 (3.8%) | 8239 / 100990 (8.2%) | −63.9 | −61.9 | 0.47 |
| ARID1A SRX5089391 | MCF-7 Breast | 163 / 10099 (1.6%) | 4931 / 100990 (4.9%) | −63.8 | −61.9 | 0.33 |
| FOXA1 SRX1961158 | T-47D Breast | 279 / 10099 (2.8%) | 6718 / 100990 (6.7%) | −63.8 | −61.9 | 0.42 |
| FOS SRX3322637 | MCF-7 Breast | 158 / 10099 (1.6%) | 4850 / 100990 (4.8%) | −63.8 | −61.8 | 0.33 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 274 / 10099 (2.7%) | 6641 / 100990 (6.6%) | −63.7 | −61.8 | 0.41 |
| ARID5B SRX3230377 | Hep G2 Liver | 659 / 10099 (6.5%) | 11888 / 100990 (11.8%) | −63.7 | −61.8 | 0.55 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 82 / 10099 (0.8%) | 3521 / 100990 (3.5%) | −63.6 | −61.7 | 0.23 |
| RBM22 SRX4708083 | K-562 Blood | 491 / 10099 (4.9%) | 1941 / 100990 (1.9%) | −63.5 | −61.6 | 2.53 |
| FOXA1 SRX3923518 | MCF-7 Breast | 204 / 10099 (2.0%) | 5571 / 100990 (5.5%) | −63.5 | −61.5 | 0.37 |
| CDK9 SRX7366780 | MCF-7 Breast | 110 / 10099 (1.1%) | 79 / 100990 (0.1%) | −63.4 | −61.5 | 13.92 |
| ESR1 SRX8537723 | MCF-7 Breast | 223 / 10099 (2.2%) | 5861 / 100990 (5.8%) | −63.4 | −61.5 | 0.38 |
| ZEB1 SRX13298924 | MCF-7 Breast | 139 / 10099 (1.4%) | 4518 / 100990 (4.5%) | −63.3 | −61.3 | 0.31 |
| FOXA1 SRX1161172 | MCF-7 Breast | 280 / 10099 (2.8%) | 6709 / 100990 (6.6%) | −63.1 | −61.2 | 0.42 |
| ESR1 SRX5323878 | MCF-7 Breast | 280 / 10099 (2.8%) | 6698 / 100990 (6.6%) | −62.9 | −60.9 | 0.42 |
| FOXA1 SRX5203303 | MCF-7 Breast | 102 / 10099 (1.0%) | 3856 / 100990 (3.8%) | −62.7 | −60.7 | 0.26 |
| FOXA1 SRX15430999 | T-47D Breast | 317 / 10099 (3.1%) | 7221 / 100990 (7.2%) | −62.6 | −60.6 | 0.44 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 317 / 10099 (3.1%) | 7218 / 100990 (7.1%) | −62.5 | −60.5 | 0.44 |
| ARID1A SRX5089388 | MCF-7 Breast | 151 / 10099 (1.5%) | 4688 / 100990 (4.6%) | −62.4 | −60.5 | 0.32 |
| AR SRX1067070 | LHSAR Prostate | 650 / 10099 (6.4%) | 11705 / 100990 (11.6%) | −62.4 | −60.4 | 0.56 |
| Epitope tags SRX2867680 | 293 Kidney | 1119 / 10099 (11.1%) | 6415 / 100990 (6.4%) | −62.3 | −60.4 | 1.74 |
| ZFX SRX7805372 | 293 Kidney | 817 / 10099 (8.1%) | 4169 / 100990 (4.1%) | −62.3 | −60.4 | 1.96 |
| FOXA1 SRX3923519 | MCF-7 Breast | 184 / 10099 (1.8%) | 5209 / 100990 (5.2%) | −62.2 | −60.3 | 0.35 |
| ESR1 SRX10365533 | MCF-7 Breast | 141 / 10099 (1.4%) | 4509 / 100990 (4.5%) | −62.1 | −60.2 | 0.31 |
| JUNB SRX8488074 | SUM 229PE Breast | 373 / 10099 (3.7%) | 7995 / 100990 (7.9%) | −62.1 | −60.2 | 0.47 |
| ESR1 SRX1012633 | MCF-7 Breast | 148 / 10099 (1.5%) | 4628 / 100990 (4.6%) | −62.1 | −60.2 | 0.32 |
| AR SRX9109113 | MDA-MB-453 Breast | 508 / 10099 (5.0%) | 9828 / 100990 (9.7%) | −62.0 | −60.1 | 0.52 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 246 / 10099 (2.4%) | 6151 / 100990 (6.1%) | −61.8 | −59.9 | 0.40 |
| FOXA1 SRX5323845 | MCF-7 Breast | 116 / 10099 (1.1%) | 4069 / 100990 (4.0%) | −61.6 | −59.6 | 0.29 |
| ESR1 SRX10365558 | MCF-7 Breast | 197 / 10099 (2.0%) | 5390 / 100990 (5.3%) | −61.5 | −59.6 | 0.37 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 170 / 10099 (1.7%) | 4963 / 100990 (4.9%) | −61.5 | −59.6 | 0.34 |
| FOXA1 SRX3923515 | MCF-7 Breast | 171 / 10099 (1.7%) | 4981 / 100990 (4.9%) | −61.5 | −59.6 | 0.34 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 345 / 10099 (3.4%) | 7572 / 100990 (7.5%) | −61.4 | −59.5 | 0.46 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 124 / 10099 (1.2%) | 4200 / 100990 (4.2%) | −61.4 | −59.5 | 0.30 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 347 / 10099 (3.4%) | 1125 / 100990 (1.1%) | −61.3 | −59.4 | 3.08 |
| AR SRX9109110 | MDA-MB-453 Breast | 503 / 10099 (5.0%) | 9731 / 100990 (9.6%) | −61.3 | −59.4 | 0.52 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 881 / 10099 (8.7%) | 4659 / 100990 (4.6%) | −61.3 | −59.4 | 1.89 |
| ESR1 SRX5323871 | MCF-7 Breast | 305 / 10099 (3.0%) | 6990 / 100990 (6.9%) | −61.1 | −59.2 | 0.44 |
| ESR1 SRX1469949 | MCF-7 Breast | 165 / 10099 (1.6%) | 4867 / 100990 (4.8%) | −61.0 | −59.1 | 0.34 |
| FOXA1 SRX5323829 | T-47D Breast | 167 / 10099 (1.7%) | 4894 / 100990 (4.8%) | −60.9 | −58.9 | 0.34 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 445 / 10099 (4.4%) | 8930 / 100990 (8.8%) | −60.8 | −58.9 | 0.50 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 761 / 10099 (7.5%) | 13029 / 100990 (12.9%) | −60.8 | −58.9 | 0.58 |
| SP1 SRX190358 | HCT 116 Digestive tract | 418 / 10099 (4.1%) | 8559 / 100990 (8.5%) | −60.7 | −58.8 | 0.49 |
| JUNB SRX10119383 | MCF 10A Breast | 204 / 10099 (2.0%) | 5467 / 100990 (5.4%) | −60.6 | −58.7 | 0.37 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 186 / 10099 (1.8%) | 344 / 100990 (0.3%) | −60.6 | −58.7 | 5.41 |
| ESR1 SRX1012630 | MCF-7 Breast | 114 / 10099 (1.1%) | 4000 / 100990 (4.0%) | −60.5 | −58.6 | 0.28 |
| VGLL1 SRX18013277 | FULVR Breast | 132 / 10099 (1.3%) | 4301 / 100990 (4.3%) | −60.5 | −58.5 | 0.31 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 334 / 10099 (3.3%) | 7372 / 100990 (7.3%) | −60.4 | −58.5 | 0.45 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 199 / 10099 (2.0%) | 5380 / 100990 (5.3%) | −60.4 | −58.5 | 0.37 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 305 / 10099 (3.0%) | 6962 / 100990 (6.9%) | −60.4 | −58.5 | 0.44 |
| FOXA1 SRX1161205 | T-47D Breast | 164 / 10099 (1.6%) | 4820 / 100990 (4.8%) | −60.2 | −58.3 | 0.34 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 563 / 10099 (5.6%) | 2467 / 100990 (2.4%) | −60.0 | −58.1 | 2.28 |
| EP300 SRX176883 | MCF-7 Breast | 141 / 10099 (1.4%) | 4435 / 100990 (4.4%) | −60.0 | −58.1 | 0.32 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 123 / 10099 (1.2%) | 4131 / 100990 (4.1%) | −59.9 | −58.0 | 0.30 |
| FOSL2 SRX190204 | A549 Lung | 287 / 10099 (2.8%) | 6677 / 100990 (6.6%) | −59.8 | −57.9 | 0.43 |
| ESR1 SRX5323872 | MCF-7 Breast | 287 / 10099 (2.8%) | 6677 / 100990 (6.6%) | −59.8 | −57.9 | 0.43 |
| ESR1 SRX20282966 | MCF-7 Breast | 107 / 10099 (1.1%) | 3851 / 100990 (3.8%) | −59.7 | −57.8 | 0.28 |
| MAU2 SRX11120893 | MCF-7 Breast | 126 / 10099 (1.2%) | 4177 / 100990 (4.1%) | −59.7 | −57.8 | 0.30 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 200 / 10099 (2.0%) | 5366 / 100990 (5.3%) | −59.6 | −57.7 | 0.37 |
| FOXA1 SRX5203294 | MCF-7 Breast | 94 / 10099 (0.9%) | 3613 / 100990 (3.6%) | −59.6 | −57.7 | 0.26 |
| SMAD3 SRX366168 | NCI-H441 Lung | 256 / 10099 (2.5%) | 6204 / 100990 (6.1%) | −59.4 | −57.5 | 0.41 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 206 / 10099 (2.0%) | 5452 / 100990 (5.4%) | −59.4 | −57.5 | 0.38 |
| ESR1 SRX5323877 | MCF-7 Breast | 228 / 10099 (2.3%) | 5784 / 100990 (5.7%) | −59.3 | −57.4 | 0.39 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 232 / 10099 (2.3%) | 5841 / 100990 (5.8%) | −59.3 | −57.4 | 0.40 |
| ESR1 SRX2513521 | MCF-7 Breast | 142 / 10099 (1.4%) | 4424 / 100990 (4.4%) | −59.1 | −57.2 | 0.32 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 815 / 10099 (8.1%) | 4242 / 100990 (4.2%) | −59.0 | −57.1 | 1.92 |
| AHR SRX20282969 | MCF-7 Breast | 141 / 10099 (1.4%) | 4404 / 100990 (4.4%) | −59.0 | −57.1 | 0.32 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 295 / 10099 (2.9%) | 6756 / 100990 (6.7%) | −58.9 | −57.0 | 0.44 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 399 / 10099 (4.0%) | 8215 / 100990 (8.1%) | −58.9 | −57.0 | 0.49 |
| SREBF2 SRX5359049 | HCC70 Breast | 613 / 10099 (6.1%) | 2828 / 100990 (2.8%) | −58.8 | −56.9 | 2.17 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 115 / 10099 (1.1%) | 3953 / 100990 (3.9%) | −58.7 | −56.8 | 0.29 |
| RNF2 SRX18954719 | SCC-25 Others | 388 / 10099 (3.8%) | 8053 / 100990 (8.0%) | −58.6 | −56.7 | 0.48 |
| ESR1 SRX11120903 | MCF-7 Breast | 251 / 10099 (2.5%) | 6101 / 100990 (6.0%) | −58.6 | −56.7 | 0.41 |
| KMT2C SRX1787675 | MCF-7 Breast | 257 / 10099 (2.5%) | 6181 / 100990 (6.1%) | −58.4 | −56.6 | 0.42 |
| FOXA1 SRX6878603 | LNCAP Prostate | 327 / 10099 (3.2%) | 7195 / 100990 (7.1%) | −58.4 | −56.5 | 0.45 |
| NCOA3 SRX4663589 | MCF-7 Breast | 94 / 10099 (0.9%) | 3576 / 100990 (3.5%) | −58.4 | −56.5 | 0.26 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 262 / 10099 (2.6%) | 6254 / 100990 (6.2%) | −58.4 | −56.5 | 0.42 |
| Epitope tags SRX5877913 | U2OS Bone | 1372 / 10099 (13.6%) | 20224 / 100990 (20.0%) | −58.4 | −56.5 | 0.68 |
| ESR1 SRX1012628 | MCF-7 Breast | 153 / 10099 (1.5%) | 4574 / 100990 (4.5%) | −58.3 | −56.4 | 0.33 |
| ESR1 SRX2881001 | MCF-7 Breast | 165 / 10099 (1.6%) | 4767 / 100990 (4.7%) | −58.3 | −56.4 | 0.35 |
| ESR1 SRX1469951 | MCF-7 Breast | 155 / 10099 (1.5%) | 4606 / 100990 (4.6%) | −58.2 | −56.4 | 0.34 |
| FOXA1 SRX3931033 | MCF-7 Breast | 200 / 10099 (2.0%) | 5316 / 100990 (5.3%) | −58.2 | −56.3 | 0.38 |
| ESR1 SRX1012625 | MCF-7 Breast | 160 / 10099 (1.6%) | 4683 / 100990 (4.6%) | −58.2 | −56.3 | 0.34 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 277 / 10099 (2.7%) | 6463 / 100990 (6.4%) | −58.1 | −56.3 | 0.43 |
| STAT3 SRX5323860 | MCF-7 Breast | 360 / 10099 (3.6%) | 7644 / 100990 (7.6%) | −58.1 | −56.3 | 0.47 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 254 / 10099 (2.5%) | 6126 / 100990 (6.1%) | −58.1 | −56.3 | 0.41 |
| PRRX1 SRX15235713 | Hs 578T Breast | 354 / 10099 (3.5%) | 7558 / 100990 (7.5%) | −58.0 | −56.2 | 0.47 |
| FOXA1 SRX100477 | Hep G2 Liver | 340 / 10099 (3.4%) | 7362 / 100990 (7.3%) | −58.0 | −56.2 | 0.46 |
| ESR1 SRX2513517 | MCF-7 Breast | 201 / 10099 (2.0%) | 5321 / 100990 (5.3%) | −58.0 | −56.1 | 0.38 |
| FOXA1 SRX6860635 | T-47D Breast | 229 / 10099 (2.3%) | 5745 / 100990 (5.7%) | −57.8 | −56.0 | 0.40 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 202 / 10099 (2.0%) | 5330 / 100990 (5.3%) | −57.8 | −56.0 | 0.38 |
| GRHL2 SRX268451 | Tracheal epithelial cells Lung | 195 / 10099 (1.9%) | 5223 / 100990 (5.2%) | −57.8 | −55.9 | 0.37 |
| JUND SRX092301 | K-562 Blood | 376 / 10099 (3.7%) | 7839 / 100990 (7.8%) | −57.5 | −55.6 | 0.48 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 301 / 10099 (3.0%) | 6780 / 100990 (6.7%) | −57.5 | −55.6 | 0.44 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 654 / 10099 (6.5%) | 11502 / 100990 (11.4%) | −57.3 | −55.4 | 0.57 |
| ESR1 SRX1012631 | MCF-7 Breast | 135 / 10099 (1.3%) | 4238 / 100990 (4.2%) | −57.1 | −55.3 | 0.32 |
| MECOM SRX23677890 | HNT-34 Blood | 941 / 10099 (9.3%) | 5228 / 100990 (5.2%) | −57.1 | −55.2 | 1.80 |
| FOXA1 SRX5323830 | T-47D Breast | 186 / 10099 (1.8%) | 5054 / 100990 (5.0%) | −57.0 | −55.2 | 0.37 |
| STAT3 SRX150479 | MCF 10A Breast | 287 / 10099 (2.8%) | 6560 / 100990 (6.5%) | −57.0 | −55.1 | 0.44 |
| ESR1 SRX2912055 | MCF-7 Breast | 125 / 10099 (1.2%) | 4065 / 100990 (4.0%) | −57.0 | −55.1 | 0.31 |
| HSF1 SRX8512779 | HCT 116 Digestive tract | 84 / 10099 (0.8%) | 39 / 100990 (0.0%) | −56.9 | −55.1 | 21.54 |
| FOSL2 SRX190224 | MCF-7 Breast | 118 / 10099 (1.2%) | 3946 / 100990 (3.9%) | −56.9 | −55.1 | 0.30 |
| FOXA1 SRX1161207 | T-47D Breast | 134 / 10099 (1.3%) | 4212 / 100990 (4.2%) | −56.9 | −55.0 | 0.32 |
| ESR1 SRX3110723 | MCF-7 Breast | 171 / 10099 (1.7%) | 4811 / 100990 (4.8%) | −56.8 | −54.9 | 0.36 |
| ESR1 SRX330068 | MCF-7 Breast | 148 / 10099 (1.5%) | 4440 / 100990 (4.4%) | −56.7 | −54.9 | 0.33 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 105 / 10099 (1.0%) | 3715 / 100990 (3.7%) | −56.7 | −54.9 | 0.28 |
| FOXA1 SRX5323846 | MCF-7 Breast | 129 / 10099 (1.3%) | 4127 / 100990 (4.1%) | −56.7 | −54.9 | 0.31 |
| MLLT1 SRX10131668 | Bronchial tracheal epithelial cells Lung | 95 / 10099 (0.9%) | 63 / 100990 (0.1%) | −56.7 | −54.9 | 15.08 |
| FOS SRX070879 | HUVEC Cardiovascular | 319 / 10099 (3.2%) | 7009 / 100990 (6.9%) | −56.7 | −54.8 | 0.46 |
| TP53 SRX3102569 | SW 480 Digestive tract | 542 / 10099 (5.4%) | 10025 / 100990 (9.9%) | −56.7 | −54.8 | 0.54 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 446 / 10099 (4.4%) | 8752 / 100990 (8.7%) | −56.6 | −54.8 | 0.51 |
| AR SRX1067067 | LHSAR Prostate | 489 / 10099 (4.8%) | 9326 / 100990 (9.2%) | −56.6 | −54.8 | 0.52 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 198 / 10099 (2.0%) | 5224 / 100990 (5.2%) | −56.6 | −54.7 | 0.38 |
| GRHL3 SRX2582161 | NHEK Epidermis | 464 / 10099 (4.6%) | 1896 / 100990 (1.9%) | −56.5 | −54.7 | 2.45 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 643 / 10099 (6.4%) | 3084 / 100990 (3.1%) | −56.5 | −54.7 | 2.08 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 248 / 10099 (2.5%) | 5959 / 100990 (5.9%) | −56.1 | −54.2 | 0.42 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 235 / 10099 (2.3%) | 5758 / 100990 (5.7%) | −56.0 | −54.1 | 0.41 |
| FOXA1 SRX9550928 | Prostate cancer Prostate | 373 / 10099 (3.7%) | 7730 / 100990 (7.7%) | −55.9 | −54.1 | 0.48 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 486 / 10099 (4.8%) | 9250 / 100990 (9.2%) | −55.8 | −54.0 | 0.53 |
| SPI1 SRX2770857 | Macrophages Blood | 468 / 10099 (4.6%) | 9008 / 100990 (8.9%) | −55.8 | −53.9 | 0.52 |
| ESR1 SRX5323874 | MCF-7 Breast | 185 / 10099 (1.8%) | 4991 / 100990 (4.9%) | −55.7 | −53.9 | 0.37 |
| ESR1 SRX5534831 | MCF-7 Breast | 233 / 10099 (2.3%) | 5721 / 100990 (5.7%) | −55.7 | −53.9 | 0.41 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 308 / 10099 (3.0%) | 6806 / 100990 (6.7%) | −55.7 | −53.8 | 0.45 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 71 / 10099 (0.7%) | 3066 / 100990 (3.0%) | −55.5 | −53.7 | 0.23 |
| ESR1 SRX2513520 | MCF-7 Breast | 194 / 10099 (1.9%) | 5121 / 100990 (5.1%) | −55.5 | −53.7 | 0.38 |
| KDM6A SRX15826236 | MCF-7 Breast | 107 / 10099 (1.1%) | 3710 / 100990 (3.7%) | −55.5 | −53.7 | 0.29 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 198 / 10099 (2.0%) | 5180 / 100990 (5.1%) | −55.4 | −53.6 | 0.38 |
| ESR1 SRX5534832 | MCF-7 Breast | 279 / 10099 (2.8%) | 6379 / 100990 (6.3%) | −55.4 | −53.5 | 0.44 |
| RNF2 SRX18954704 | FaDu Others | 648 / 10099 (6.4%) | 11324 / 100990 (11.2%) | −55.3 | −53.5 | 0.57 |
| FOXA1 SRX1447316 | MCF-7 Breast | 145 / 10099 (1.4%) | 4342 / 100990 (4.3%) | −55.3 | −53.5 | 0.33 |
| VGLL1 SRX18013278 | FULVR Breast | 158 / 10099 (1.6%) | 4550 / 100990 (4.5%) | −55.3 | −53.5 | 0.35 |
| JUND SRX190357 | SK-N-SH Neural | 374 / 10099 (3.7%) | 7713 / 100990 (7.6%) | −55.3 | −53.5 | 0.48 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 82 / 10099 (0.8%) | 3262 / 100990 (3.2%) | −55.3 | −53.5 | 0.25 |
| CDK9 SRX7366784 | MCF-7 Breast | 99 / 10099 (1.0%) | 77 / 100990 (0.1%) | −55.2 | −53.4 | 12.86 |
| CBX3 SRX6712570 | MCF-7 Breast | 236 / 10099 (2.3%) | 5743 / 100990 (5.7%) | −55.1 | −53.3 | 0.41 |
| MECOM SRX23677891 | HNT-34 Blood | 929 / 10099 (9.2%) | 5206 / 100990 (5.2%) | −54.9 | −53.1 | 1.78 |
Showing first 500 of 25645 rows.